-+ 0.00%
-+ 0.00%
-+ 0.00%

Kalaris Therapeutics Unveils Phase 1 Data for TH103 in Neovascular AMD at Macula Society Meeting

Reuters·01/28/2026 21:05:34

Please log in to view news